Post by Madhukar Bose

Head of Digital Health @ UK’s Department for Business and Trade (DBT). Imperial AI Policy Fellow. Guest lecturer @ City St George’s, School of Health & Medical Sciences and UCL Global business school for health

The UK just made a bold move to back healthtech scale-ups — and it couldn’t be more timely. This week’s announcement of a £100M commitment to a specialist healthcare growth fund highlights a challenge many of us have been talking about for years: the UK doesn’t lack innovation — it lacks scale-up capital. That’s exactly the gap we addressed in our recent Healthcare UK AI Report 🟢 The Report – #HCUKGenAI 👉 https://lnkd.in/e8DjgENu In the report, we set out a clear set of proposals to: 🚀 Unlock later-stage funding for AI-driven healthcare companies 🚀 Create stronger pathways from NHS adoption to global scaling 🚀 Build an ecosystem that retains high-value companies in the UK 🚀 Align public funding with commercial growth, not just early research This latest investment is a strong signal that policymakers are starting to move in that direction. But capital alone isn’t enough and the report proposes key additional steps 🕝 Model development & data access: Establish secure, standardised access to NHS data environments and trusted research environments (TREs) to enable scalable AI model training and validation 🕝 Procurement streamlining with clearer national pathways, reducing fragmentation and enabling faster adoption of proven AI solutions 🕝 Deployment infrastructure investment so AI tools can integrate seamlessly across care settings 🕝 Evidence & validation through consistent, proportionate evaluation frameworks to avoid duplicating effort. 🕝 Commercial scaling pathways with structured routes to regional and national rollout The opportunity is enormous, but so is the risk of falling behind if we don’t connect these pieces. Moments like this £100M commitment are important — but their real impact depends on whether they’re matched with the structural changes needed to turn innovation into scaled deployment. If you’re working in healthtech, AI, or policy, the report is worth a read. It lays out practical steps to turn investment into long-term advantage. Dr Keith Grimes, Haris Shuaib,Youssof Oskrochi, Robin Carpenter, Minal Bakhai MBE, Pearse Keane, David Lowe, Stephen J. Duffield, Fiona Reddington, Pritesh Mistry, Umang Patel, Dr. Vishaal Virani, MBBS,Gary McAllister, Neville Young, Erica Warp, Dr Mike Short CBE FREng FIET FBCS FITP, Louis Taylor CBE, Alastair Denniston, Lawrence Tallon, Richard Stubbs, Rishi Das-Gupta, Dominique Allwood, Chris Laing, Hatim Abdulhussein, Demis Hassabis, Megan Morys-Carter Brishni Mukhopadhyay, CFA Healthcare UK Matt Clifford Melanie Ivarsson OBE